GPT Healthcare IPO Details, Timeline, Price, GMP, FAQs
GPT Healthcare Limited
GPT Healthcare IPO Details
IPO Open
22 Feb 2024
IPO Close
26 Feb 2024
Price Band
₹177 – ₹186
Issue Size
₹525 Cr
Listing on
BSE, NSE
Min. Lot Size
80
Face value
₹10
GMP
₹0
GPT Healthcare IPO Timeline
IPO Open
22 Feb 2024
IPO Close
26 Feb 2024
Allotment
27 Feb 2024
Refund initiation
28 Feb 2024
Demat transfer
28 Feb 2024
Listing
29 Feb 2024
Key Performance Indicators
Debt/Equity
0.39
P/E
38.1
EPS
4.88
ROE
23.59%
ROCE
26.09%
Sector
Medical
About GPT Healthcare Limited
GPT Healthcare Limited was established in 2000 by Dr. Om Tantia, a respected surgeon, under the ILS Hospitals brand. Part of the GPT Group, a larger company involved in real estate, education, and infrastructure.
Currently operates 4 multispecialty hospitals in Eastern India, with plans to expand to 1000+ beds within 3 years.
Hospital Locations and Services:
- Salt Lake (Kolkata): 85 beds, focusing on Cardiology, Gastroenterology, Neurology, Oncology, Orthopedics, Urology, and more.
- Agartala (Tripura): 205 beds, known for Oncology, Nephrology, Urology, General Surgery, and Pediatrics, also hosting a nursing program.
- Dum Dum (Kolkata): 155 beds, specializing in Cardiology, Pulmonology, Nephrology, Gastroenterology, and Oncology.
- Howrah: 116 beds, offering services in Orthopedics, General Surgery, Urology, Gynecology, and Pediatrics.
GPT Healthcare Limited focuses on integrated healthcare, providing a wide range of secondary and tertiary care, including advanced diagnostics, surgeries, and treatment for various specialties. They aim to deliver quality healthcare at affordable prices, making it accessible to a wider population.
Recognized for its patient-centric approach and commitment to ethical medical practices. GPT Healthcare Limited Awarded the “Most Trusted Multispecialty Hospital in West Bengal” by Times Accent in February 2023.
Looking Ahead:
- Plans for expansion include more hospitals and increased bed capacity.
- Continued focus on providing specialized services and affordable healthcare in Eastern India.
- Investment in research and development to improve medical care and treatment options.
About GPT Healthcare IPO
GPT Healthcare is gearing up for its IPO, opening for subscription on February 22nd, 2024. The book-built issue aims to raise ₹525.14 crore, with a share price band of ₹177-₹186. The minimum investment amount of ₹14,880 and minimum lot size of 80 shares. Subscription closes on February 26th, with tentative listing on BSE and NSE set for February 29th.
Issue Details:
- Issue Size: ₹525.14 Crore
- Price Band: ₹177 – ₹186 per equity share
- Face Value: ₹10 per share
- Market Cap (Based on Upper Price Band): ₹1526.22 Crore
- Fresh Issue: ₹40 Crore
- Offer for Sale: ₹485.14 Crore
- Minimum Order Quantity: 80 Shares
- Listing: BSE & NSE
Timeline:
- Subscription Opens: February 22, 2024
- Subscription Closes: February 26, 2024
- Allotment Finalization: February 27, 2024 (expected)
- Tentative Listing Date: February 29, 2024
Other Key Points:
- Market Segment: Main Board
- Book Built Issue: Yes
- Lead Manager: ICICI Securities Limited, Edelweiss Financial Services Limited, SBI Capital Markets Limited
- Registrar: Link Intime India Private Ltd
Industry Overview
GPT Healthcare operates within a dynamic and growing sector of the Indian healthcare industry: hospital management and multi-specialty healthcare. Here is few key trends and factors:
Market Growth:
- The Indian hospital industry is expected to reach USD 372 billion by 2026, growing at a CAGR of 16-17%.
- This growth is driven by factors like rising disposable incomes, increasing health awareness, aging population, and expanding medical insurance coverage.
Shift towards Multi-Specialty:
- There’s a growing demand for multi-specialty hospitals offering a wider range of services under one roof. This provides convenience and comprehensive care for patients.
- GPT Healthcare, with its 4 multi-specialty hospitals, aligns with this trend.
Technological Advancements:
- Hospitals are increasingly adopting technologies like telemedicine, robotic surgery, and electronic health records (EHRs) to improve efficiency, accuracy, and patient experience.
- GPT Healthcare’s commitment to investing in R&D suggests their potential to adapt to this trend.
Competition:
- The hospital management sector is becoming increasingly competitive, with both domestic and international players vying for market share.
- This highlights the importance of strategic expansion, service differentiation, and cost-effectiveness for success, areas where GPT Healthcare could focus.
Challenges:
- Despite the growth, the industry faces challenges like rising healthcare costs, regulatory complexities, and manpower shortages.
- Navigating these challenges will be crucial for GPT Healthcare’s long-term success.
Opportunities:
- The sector offers opportunities for expansion into Tier-2 and Tier-3 cities, where access to quality healthcare is often limited.
- GPT Healthcare’s existing presence in Eastern India positions them to capitalize on this potential.
Overall, the hospital management and multi-specialty healthcare sector in India presents a promising landscape for growth. However, understanding the market dynamics, competition, and challenges is crucial for players like GPT Healthcare to navigate the environment and achieve sustainable success.
Peer Analysis
Here’s a comparative peer analysis of GPT Healthcare against some of its listed peers in the hospital management and multi-specialty healthcare sector in India:
Financials:
- GPT Healthcare:
- Revenue: 361 Cr (lower)
- Profit: 39 Cr (lower)
- ROE: 23.77%
- Market Cap: 1,526.22 Cr (estimated)
- P/E Ratio: N/A (upcoming IPO)
- Global Health:
- Revenue: 1,030 Cr (highest)
- Profit: 188 Cr (highest)
- ROE: 24.53%
- Market Cap: 12,923 Cr
- P/E Ratio: 68.73
- Krishna Institute:
- Revenue: 731 Cr
- Profit: 176 Cr
- ROE: 23.61%
- Market Cap: 9,164 Cr
- P/E Ratio: 52.06
- Jupiter Life Line:
- Revenue: 292 Cr
- Profit: 63 Cr
- ROE: 21.74%
- Market Cap: 12,879 Cr
- P/E Ratio: 204.75
- Yatharth Hospital:
- Revenue: 297 Cr
- Profit: 57 Cr
- ROE: 44.20% (highest)
- Market Cap: 3,905 Cr
- P/E Ratio: 68.50
Hospitals & Beds:
- GPT Healthcare:
- Hospitals: 4 (lowest)
- Beds: 561 (lower)
- Global Health:
- Hospitals: 13 (highest)
- Beds: 2,200+
- Krishna Institute:
- Hospitals: 5
- Beds: 1,100+
- Jupiter Life Line:
- Hospitals: 3
- Beds: 450+
- Yatharth Hospital:
- Hospitals: 8
- Beds: 800+
Core Specialties:
- All offer Cardiology, Oncology, and Orthopedics.
- GPT Healthcare: Additional specialties include Gastroenterology and Nephrology.
- Krishna Institute: Additional specialties include Neurosurgery and Joint Replacement.
- Jupiter Life Line: Additional specialties include Cardiac Care, Spine Surgery, and Neuro Sciences.
- Yatharth Hospital: Additional specialties include Urology.
Geographic Reach:
- GPT Healthcare: Strong presence in Eastern India, limited national reach.
- Global Health: Pan-India presence, strongest in South and West.
- Krishna Institute: Primarily South India, expanding nationally.
- Jupiter Life Line: Mainly Western India, focused on metros.
- Yatharth Hospital: Central India focus, expanding to other regions.
Specific Specialty Strengths:
- GPT Healthcare: Affordable care, focus on secondary and tertiary care.
- Global Health: Oncology, pediatrics, neurology.
- Krishna Institute: Cardiac care, neurosurgery, joint replacement.
- Jupiter Life Line: Cardiac care, spine surgery, joint replacement.
- Yatharth Hospital: Urology, oncology, cardiology.
Technology Adoption:
- GPT Healthcare: Invests heavily in AI, self-service platforms, and telemedicine.
- Global Health: Implementing digital initiatives, but not as advanced as GPT.
- Krishna Institute: Focus on research and education, technology adoption in select areas.
- Jupiter Life Line: Implementing electronic health records and patient engagement tools.
- Yatharth Hospital: Investing in digital infrastructure and patient portals.
Brand Reputation:
- GPT Healthcare: Strong regional brand in Eastern India, growing national recognition.
- Global Health: Established national brand, but perceived as expensive.
- Krishna Institute: Strong brand in South India, known for medical education.
- Jupiter Life Line: Growing brand in Western India, known for specialized services.
- Yatharth Hospital: Strong brand in Central India, building national presence.
GPT Healthcare IPO Reservation
| Investor Category | Shares Offered |
|---|---|
| QIB | Not more than 50.00% of the Net offer |
| Retail | Not less than 35.00% of the Offer |
| HNI | Not less than 15.00% of the Offer |
GPT Healthcare IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 80 | ₹14,880 |
| Retail (Max) | 13 | 1040 | ₹193,440 |
| S-HNI (Min) | 14 | 1,120 | ₹208,320 |
| S-HNI (Max) | 67 | 5,360 | ₹996,960 |
| B-HNI (Min) | 68 | 5,440 | ₹1,011,840 |
Financials of GPT Healthcare Limited
| Mar 2023 | Mar 2022 | Mar 2021 | |
|---|---|---|---|
| Assets | 326.76 | 323.22 | 317.21 |
| Revenue | 366.73 | 342.4 | 248.86 |
| Profit After Tax | 39.01 | 41.66 | 21.09 |
| Net Worth | 164.14 | 156.96 | 132.68 |
| Reserves and Surplus | 85.46 | 78.28 | 75.96 |
| Total Borrowing | 64.67 | 95.52 | 122.93 |
- Assets: Up 1.1% in Mar 2023, indicating steady growth.
- Revenue: Up 7% in Mar 2023, demonstrating positive business momentum.
- Profit After Tax (PAT): Down 6.6% in Mar 2023, needs investigation into the cause.
- Net Worth: Up 4.5% in Mar 2023, suggesting strengthening financial position.
- Reserves & Surplus: Up 9.2% in Mar 2023, indicating healthy internal reserves.
- Total Borrowing: Significant jump of 47.7% in Mar 2023, warrants closer examination.
Objective of GPT Healthcare IPO
- The company intends to repay or prepay, in full or in part, outstanding borrowings obtained from banks and financial institutions.
- General corporate purposes.
Promoter Share Holding Pattern
As of September 30, 2023, the promoter shareholding in GPT Healthcare is 65.58%. This is down from 67.34% before the company’s initial public offering (IPO) in July 2023.
Here’s the breakdown of the promoter shareholding:
- Dwarika Prasad Tantia: 5.00%
- GPT Sons Private Limited: 8.72%
- Dr. Om Tantia: 23.41%
- Shree Gopal Tantia: 28.45%
FAQ about CGPT Healthcare IPOompany
GPT Healthcare IPO opens on February 22, 2024.
GPT Healthcare IPO closes on February 26, 2024.
GPT Healthcare IPO price band is ₹177 – ₹186 per equity share.
The issue size for the GPT Healthcare IPO is ₹525 crore.
GPT Healthcare will be listed on the BSE and NSE.
The minimum lot size for the GPT Healthcare IPO is 2000 shares.
The face value of GPT Healthcare shares is ₹10.
GPT Healthcare IPO GMP is ₹0.
The lead managers for the GPT Healthcare IPO are ICICI Securities Limited, Edelweiss Financial Services Limited, and SBI Capital Markets Limited.
The debt/equity ratio of GPT Healthcare is 0.39.
The P/E ratio of GPT Healthcare is 38.1.
The EPS of GPT Healthcare is ₹4.88.
The ROE of GPT Healthcare is 23.59%.
The ROCE of GPT Healthcare is 26.09%.
The promoters of GPT Healthcare are Dwarika Prasad Tantia, GPT Sons Private Limited, Dr. Om Tantia, and Shree Gopal Tantia.
GPT Healthcare IPO Subscription Status
| Category | Subscription Times |
|---|---|
| Qualified Institutional Buyers | 0.0 X |
| Retail Individual Investor | 0.0 X |
| Non-Instituional Investor | 0.0 X |
| Total | 0.0 X |
